Business : Fortrea Expands Early-Phase Trial Capacity With US$45 Mln Deal
KUALA LUMPUR, Oct 20 (Bernama) -- Contract research organisation Fortrea has completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials, in an all-cash transaction valued at approximately US$45 million. (US$1 = RM4.07)
We haven't written up this one. Bernama has the full story — the link below goes straight to it.